Richard Graydon
Direttore Tecnico/Scientifico/R&S presso ATOSSA THERAPEUTICS, INC.
Profilo
Dr. Richard Graydon is a Chief Medical Officer at Atossa Therapeutics, Inc. Dr. Graydon was previously employed as a Director-Clinical Development by Daiichi Sankyo, Inc. He received his undergraduate degree from Cornell University and a doctorate degree from Stanford University.
Posizioni attive di Richard Graydon
| Società | Posizione | Inizio |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 25/10/2022 |
Precedenti posizioni note di Richard Graydon
| Società | Posizione | Fine |
|---|---|---|
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Richard Graydon
| Stanford University | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
- Borsa valori
- Insiders
- Richard Graydon
